Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF9, BMS-663513 Vector   (CAT#: GTVCR-WQ746MR)

This product GTVCR-WQ746MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting TNFRSF9. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001561.6
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3604
UniProt ID Q07011
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF9, BMS-663513 Vector (GTVCR-WQ746MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1160MR IVTScrip™ pSP6-VEE-mRNA-Anti-Alkaline phosphatase substitute, ENB-0040 Vector Vector ENB-0040
GTVCR-WQ1122MR IVTScrip™ pSP6-VEE-mRNA-Anti-MUC16, DMUC5754A Vector Vector DMUC5754A
GTVCR-WQ2658MR IVTScrip™ pSP6-VEE-mRNA-Anti-SLC34A2, XMT-1536 Vector Vector XMT-1536
GTVCR-WQ1179MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR, Fab C225 Vector Vector Fab C225
GTVCR-WQ2638MR IVTScrip™ pSP6-VEE-mRNA-Anti-CA9, WX-G250 Vector Vector WX-G250
GTVCR-WQ767MR IVTScrip™ pT7-VEE-mRNA-Anti-CXCR4, BMS-936564 Vector Vector BMS-936564
GTVCR-WQ1682MR IVTScrip™ pSP6-VEE-mRNA-Anti-FN, L19-131 I Vector Vector L19-131 I
GTVCR-WQ2155MR IVTScrip™ pT7-VEE-mRNA-Anti-TNF, OPRX-106 Vector Vector OPRX-106
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.